Keda Yu

24PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 16, 2026
A fusion-deletion genomic-event underlies poor prognosis in young patients with luminal breast cancer.

|Jan 13, 2026
Multi-omics analysis reveals comprehensive aberrant protein and phosphorylation characteristics in breast cancer and paired metastatic lymph nodes.

Linhui Zhai, Cui-Cui Liu, Lei Zhao

|Apr 14, 2025
SNX10 deficiency impairs sensitivity to anti-HER2 antibody-drug conjugates via altering HER2 trafficking in HER2-positive breast cancer.

Yu-Fei Chen, Qing-Hua Zhang, Zhong-Wei Zhang

|Feb 24, 2025
Circulating Tumor Microenvironment in Metastasis.

Rui Tang, Shujuan Luo, Hui Liu

|Feb 18, 2025
Breast cancer: pathogenesis and treatments.

Xin Xiong, Le-Wei Zheng, Yu Ding

|Jan 04, 2025
A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2- breast cancer-FINEST study.

Li Chen, Wen-Ya Wu, Fei Liang

Pageof 4

Frequent Collaborators

2 joint publications

Zhi-Ming Shao

2 joint publications

Haojun Luo

2 joint publications

Zhi-Ming Shao

1 joint publications

Sufyan Suleman